Kang Healthcare (KANG) Tops Q2 EPS by 1c, Reaffirms FY Guidance

Kang Healthcare (NASDAQ: KANG) reported Q2 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $79.6 million versus the consensus estimate of $79.1 million. Kang Healthcare reaffirmed FY2014 guidance.

GUIDANCE FOR FISCAL YEAR ENDING MARCH 31, 2015

For the fiscal year ending March 31, 2015, the Company reaffirms its guidance of net revenues to be between US$283 million and US$290 million, representing a year-on-year increase between 40.0% and 43.4%.

For earnings history and earnings-related data on Kang Healthcare (KANG) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Amphenol (APH) Reports Q1, Announces $2B Share Buyback
• Bunge Limited (BG) Tops Q1 EPS by 50c, misses on revenue and guidance